venetoclax rituximab for r/r cll: 7-year results of the murano trial
Published 1 year ago • 293 plays • Length 2:13Download video MP4
Download video MP3
Similar videos
-
2:25
update from murano trial: venetoclax-rituximab leads to slower clonal growth rate in cll
-
1:01
pirtobrutinib, venetoclax, and rituximab in the treatment of r/r cll: insights from the bruin trial
-
6:25
murano: five-year follow-up on venetoclax plus rituximab for cll
-
3:12
results of the murano study for cll
-
2:29
combo of rg6146/venetoclax/rituximab for r/r dlbcl: initial data
-
5:17
venetoclax and rituximab: changing the treatment landscape in r/r cll
-
2:57
murano trial: duvelisib plus venetoclax in r/r cll, sll and richter’s syndrome
-
4:22
discover versiti diagnostic labs, clinical trials and biomaterials | versiti
-
4:52
apoptosis and venetoclax
-
24:09
update on venetoclax for cll
-
2:20
murano: venetoclax rituximab in birc3-mutated r/r cll
-
2:04
time-limited venetoclax-rituximab in r/r cll patients previously exposed to btki’s
-
1:51
the safety and efficacy of retreatment with venetoclax plus rituximab in r/r cll
-
2:05
results from the phase i sal-relax trial: venetoclax plus cytarabine and mitoxantrone in r/r aml
-
2:21
updates from the murano trial
-
1:10
impacts of the murano study for future cll treatment
-
2:04
murano trial: revolutionizing the standard of care for relapsed cll patients
-
1:43
eradic trial: preliminary results of mrd-guided ibrutinib plus venetoclax vs fcr
-
6:50
venetoclax retreatment for cll
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
2:03
the use of venetoclax in r/r al amyloidosis
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial